Clinical Trials Browser

Phase 2 × OTHER_GOV × trastuzumab deruxtecan × Clear all

NCT07416253 2026-02-18

Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms